BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27932484)

  • 1. Role of Mdm2 and Mdmx in DNA repair.
    Eischen CM
    J Mol Cell Biol; 2017 Feb; 9(1):69-73. PubMed ID: 27932484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdmx promotes genomic instability independent of p53 and Mdm2.
    Carrillo AM; Bouska A; Arrate MP; Eischen CM
    Oncogene; 2015 Feb; 34(7):846-56. PubMed ID: 24608433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mdm2 promotes genetic instability and transformation independent of p53.
    Bouska A; Lushnikova T; Plaza S; Eischen CM
    Mol Cell Biol; 2008 Aug; 28(15):4862-74. PubMed ID: 18541670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdm2 affects genome stability independent of p53.
    Bouska A; Eischen CM
    Cancer Res; 2009 Mar; 69(5):1697-701. PubMed ID: 19244108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair.
    Alt JR; Bouska A; Fernandez MR; Cerny RL; Xiao H; Eischen CM
    J Biol Chem; 2005 May; 280(19):18771-81. PubMed ID: 15734743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.
    Meulmeester E; Pereg Y; Shiloh Y; Jochemsen AG
    Cell Cycle; 2005 Sep; 4(9):1166-70. PubMed ID: 16082221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse modelling of the MDM2/MDMX-p53 signalling axis.
    Tackmann NR; Zhang Y
    J Mol Cell Biol; 2017 Feb; 9(1):34-44. PubMed ID: 28096294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
    Hu B; Gilkes DM; Chen J
    Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells.
    Carrillo AM; Hicks M; Khabele D; Eischen CM
    Mol Cancer Res; 2015 Aug; 13(8):1197-205. PubMed ID: 25964101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of MDM2 and MDMX in Cancer.
    Karni-Schmidt O; Lokshin M; Prives C
    Annu Rev Pathol; 2016 May; 11():617-44. PubMed ID: 27022975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.
    Marine JC; Jochemsen AG
    Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27371671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protecting the genome from mdm2 and mdmx.
    Melo AN; Eischen CM
    Genes Cancer; 2012 Mar; 3(3-4):283-90. PubMed ID: 23150761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine double minute 2: p53-independent roads lead to genome instability or death.
    Bouska A; Eischen CM
    Trends Biochem Sci; 2009 Jun; 34(6):279-86. PubMed ID: 19447627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of MDM2 and MDMX: a structural perspective.
    Riedinger C; McDonnell JM
    Future Med Chem; 2009 Sep; 1(6):1075-94. PubMed ID: 21425995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner.
    Zhang Y; Zeng SX; Hao Q; Lu H
    Dev Biol; 2017 Mar; 423(1):34-45. PubMed ID: 28118981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of MDM2 in Promoting Genome Stability versus Instability.
    Saadatzadeh MR; Elmi AN; Pandya PH; Bijangi-Vishehsaraei K; Ding J; Stamatkin CW; Cohen-Gadol AA; Pollok KE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,4,5-Trisubstituted Imidazole-Based p53-MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers.
    Twarda-Clapa A; Krzanik S; Kubica K; Guzik K; Labuzek B; Neochoritis CG; Khoury K; Kowalska K; Czub M; Dubin G; Dömling A; Skalniak L; Holak TA
    J Med Chem; 2017 May; 60(10):4234-4244. PubMed ID: 28482147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles and regulation of MDM2 and MDMX: it is not just about p53.
    Klein AM; de Queiroz RM; Venkatesh D; Prives C
    Genes Dev; 2021 May; 35(9-10):575-601. PubMed ID: 33888565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.